The crosstalk signaling from TNFR to EGFR is constitutively activated and plays a central role in mediating TNF-activated anti-apoptotic effects via AKT signaling in NSCLC lines with EGFR-sensitive mutations. Here, EGFR is linked to non-small cell lung carcinoma.